About Adaptive Biotechnologies Adaptive Biotechnologies is a commercial-stage biotechnology company focused on translating the genetic language of the adaptive immune system into clinical products to diagnose and treat disease. Quick Links Stock Governance Filings Press Releases Adaptive Biotechnologies Reports First Quarter 2024 Financial Results 05-07-2024 at 4:05 PM EDT Adaptive Biotechnologies to Report First Quarter 2024 Financial Results on May 7, 2024 04-17-2024 at 4:05 PM EDT Adaptive Biotechnologies Provides Strategic Review Update and Announces Preliminary First Quarter 2024 Revenue 04-02-2024 at 4:05 PM EDT VIEW ALL NEWS Upcoming Events & Presentations More events are coming soon. Past Events & Presentations Adaptive Biotechnologies First Quarter Financial Results May 7, 2024 at 4:30 PM EDT Listen to webcast Adaptive Biotechnologies Q1 2024 Earnings Presentation 768 KB Adaptive Biotechnologies Business Update Apr 2, 2024 at 4:30 PM EDT Listen to webcast TD Cowen 44th Annual Healthcare Conference Mar 4, 2024 at 2:10 PM EST Listen to webcast VIEW ALL EVENTS CHANGE VOLUME 52 week high 52 week LOW MARKET CAP May 9, 2024 6:08 AM EDTData Provided by Refinitiv. Minimum 15 minutes delayed.